Funded PhD Opportunity

Exploring new Epigenetic Modifying Agents to improve Immune Checkpoint therapies in Cancer

Subject: Biomedical Sciences


Summary

Cancer therapy is currently undergoing a revolution due to the discovery of immune checkpoint therapy, as reflected in this year’s Nobel Prize for medicine [see ref1 for a highly readable account from the Nobel Academy]. This is based around up-regulating the body’s own immune response to the tumour. The promise of this new approach is that it can result in complete remission in a substantial fraction of cancer cases, even those previously very hard to treat.

The enormous success of immune checkpoint therapy in responsive tumours has meant that the focus has now shifted to identifying ways to “prime” non-responsive tumours so that they become amenable to the therapy. Epigenetic modifying agents (EMA) are a leading candidate for this, as recent work (refs in 2) has shown that co-treating with EMA can improve response to immune checkpoint therapy.

Our lab has an internationally recognised profile in epigenetics and a long history of publication in cancer and epigenetics (eg ref3). We have great familiarity with EMA such as the drug DAC, as well as having generated a number of model systems with epigenetic alterations, for the study of cancer as well as fundamental science. In particular, we have recently been examining the effects of DAC on human cell lines(refs in 4), as well as comparing this to the direct inhibition of the cells epigenetic machinery. Genome-wide scanning and bioinformatics analysis has led us to discover a novel pathway for up-regulation of the innate immune response in human cells using EMA, which we have tested functionally in the lab and find to be a valuable new avenue for exploration.

We now wish to recruit a motivated, hard-working student with a good background in cell biology/genetics/molecular biology and a strong desire to learn new techniques. In turn, we will provide training in a range of cutting-edge approaches, including bioinformatics, pyrosequencing, cell culture and transgenics. They will join a team working on a range of model systems including our genetically altered cell lines, CRISPR models and bespoke computer algorithms. The student will be provided with training and support, and will be expected to drive their project forward with the help and guidance of more senior lab members and our collaborators on this project, which include world-leading centres such as the SIBS institute in Shanghai (ref 5) and the CCRCB at Queens’ (ref 6). Previous graduates have found their skills in high demand in both cancer research and in other science careers.

1.Nobel Prize in Medicine 2018: Immune checkpoint therapy

2.Licht Cell 2015 162:938; Chiapinelli et all (same issue, p974)

3.Loughery JE, Dunne PD ….Walsh Hum Mol Genet ‘14 20:3241

4.O’Neill K, Irwin RE….Walsh Epigenetics & Chromatin 2018 11:12; Mackin SJ, O’Neill K and Walsh Epigenomics 2018

5.Guo F, …..Walsh CP…Xu, G-L Cell Stem Cell 2014 15:447

6.Dunne PD et al, Cancer Immunol Res 2016 4:582


Essential criteria

  • To hold, or expect to achieve by 15 August, an Upper Second Class Honours (2:1) Degree or equivalent from a UK institution (or overseas award deemed to be equivalent via UK NARIC) in a related or cognate field.
  • Sound understanding of subject area as evidenced by a comprehensive research proposal

Desirable Criteria

If the University receives a large number of applicants for the project, the following desirable criteria may be applied to shortlist applicants for interview.

  • Completion of Masters at a level equivalent to commendation or distinction at Ulster
  • Experience using research methods or other approaches relevant to the subject domain
  • Work experience relevant to the proposed project
  • Publications - peer-reviewed
  • Publications record appropriate to career stage
  • Experience of presentation of research findings
  • A comprehensive and articulate personal statement
  • Use of personal initiative as evidenced by record of work above that normally expected at career stage.
  • Relevant professional qualification and/or a Degree in a Health or Health related area

Funding

    The University offers the following awards to support PhD study and applications are invited from UK, EU and overseas for the following levels of support:

    Vice Chancellors Research Studentship (VCRS)

    Full award (full-time PhD fees + DfE level of maintenance grant + RTSG for 3 years).

    This scholarship will cover full-time PhD tuition fees and provide the recipient with £15,000 maintenance grant per annum for three years (subject to satisfactory academic performance). This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.

    Vice-Chancellor’s Research Bursary (VCRB)

    Part award (full-time PhD fees + 50% DfE level of maintenance grant + RTSG for 3 years).

    This scholarship will cover full-time PhD tuition fees and provide the recipient with £7,500 maintenance grant per annum for three years (subject to satisfactory academic performance). This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.

    Vice-Chancellor’s Research Fees Bursary (VCRFB)

    Fees only award (PhD fees + RTSG for 3 years).

    This scholarship will cover full-time PhD tuition fees for three years (subject to satisfactory academic performance). This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.

    Department for the Economy (DFE)

    The scholarship will cover tuition fees at the Home rate and a maintenance allowance of £ 15,009 per annum for three years. EU applicants will only be eligible for the fee’s component of the studentship (no maintenance award is provided). For Non-EU nationals the candidate must be "settled" in the UK. This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.

    Due consideration should be given to financing your studies; for further information on cost of living etc. please refer to: www.ulster.ac.uk/doctoralcollege/postgraduate-research/fees-and-funding/financing-your-studies


Other information


The Doctoral College at Ulster University


Reviews

Profile picture of Kieran O'Donnell

My experience has been great and the people that I have worked with have been amazing

Kieran O'Donnell - 3D printing of biological cells for tissue engineering applications

Watch Video  

Profile picture of Michelle Clements Clements

Completing the MRes provided me with a lot of different skills, particularly in research methods and lab skills.

Michelle Clements Clements - MRes - Life and Health Sciences

Watch Video  

Profile picture of William Crowe

Throughout my PhD I’ve been provided with continuous support and guidance by my supervisors and the staff at the University.I’ve also received many opportunities to further enhance my professional development in the form of teaching experience and presenting my work at conferences which will aid in my pursuit of a career in academia or industry.

William Crowe


Key dates

Submission deadline
Friday 7 February 2020

Interview Date
9 to 20 March 2020


Applying

Apply Online  


Campus

Coleraine campus

Coleraine campus
The feeling of community at our Coleraine campus makes for a warm and welcoming student experience.


Contact supervisor

Dr Rachelle Irwin


Other supervisors

Related Funded Opportunities

Role of B-vitamins in Epigenetic Modulation of Hypertension

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Engineering plasmid nanoparticles as a platform for delivery of therapeutics

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Diabetes

Subject: Biomedical Sciences

 View details

Graphene family materials as novel chronic wound therapeutics

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

Development and evaluation of a web-based interactive teaching tool for Optometrists

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

Investigation of microRNA regulation and function in prostate cancer

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Role of novel cardiac biomarkers in cellular senescence

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Oxygen-generating biomaterials for use in wound dressing strategies

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

The regulation of rhamnolipid biosynthesis in Burkholderia thailandensis.

Closing date:
Tuesday 1 September 2020
Subject: Biomedical Sciences

 View details

The production of rhamnolipid biosurfactant by Pseudomonas aeruginosa growing in biofilms.

Closing date:
Tuesday 1 September 2020
Subject: Biomedical Sciences

 View details

Naturally-occurring microbial biosynthetic pathways for propane

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Genomic Medicine

Subject: Biomedical Sciences

 View details

Novel fatty acid receptors in islet cells as therapeutic targets for diabetes

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Stratified Medicine

Subject: Biomedical Sciences

 View details

Interactome visualisation of ALS using virtual reality

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Novel amphibian skin peptide-analogues for the treatment of type-2 diabetes

Closing date:
Friday 18 September 2020
Subject: Biomedical Sciences

 View details

Optometry and Vision Science

Subject: Biomedical Sciences

 View details

Blue whiting protein hydrolysates for management of sarcopenia

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Targeted exendin/apelin hybrid peptides for diabetes and obesity therapy.

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

MRes in Biomedical Sciences

Subject: Biomedical Sciences

 View details

Regulation of glucose metabolism by incretin signalling

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Identifying biomarkers that may affect diabetes comorbidity

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Mental Health Diagnosis using Cognitive Analytics

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Psychology, Psychiatry and Neuroscience

 View details

The Growing Problem of Myopia: are spectacles part of the problem?

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Improving the screening and diagnosis of familial hypercholesterolemia

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

Computational approaches to investigate multimorbidity in depression

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

The role of dietary fatty acids and the gut microbiota on autoimmunity

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

A novel therapeutic targeting the inflammasome as a treatment for glaucoma.

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Nutrition and the gut microbiome: impact on brain health in older adults

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Investigation of oral and blood microbiome shifts in patients with depression.

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Vitamin D across the lifecycle to inform nutritional policies

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Epigenomic Profiling of Young Adults with Mental Health Disorders in Northern Ireland

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Investigation of the modifying effects of selenium in the relationship between methylmercury and child development

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Biomedical Sciences

 View details

Towards seeing clearly: does the shape of the eye’s optics affect our focus?

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Changing dietary patterns in the Seychelles and implications for public health

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details